TandemLife is now a part of LivaNova, Learn More Here.
COVID-19 UPDATES:The U.S. Food and Drug Administration (FDA) issued guidance on April 6, 2020 to temporarily expand the availability of devices used in extracorporeal membrane oxygenation (ECMO) therapy to address the novel coronavirus (COVID-19) public health emergency. As a result of the guidance, cardiopulmonary devices, including select devices from TandemLife | LivaNova, are now temporarily indicated for ECMO therapy greater than 6 hours. To read the full announcement, click here.
LivaNova Receives U.S. FDA 510(k) Clearance for LifeSPARC Advanced Circulatory Support System The versatile and compact system offers the power and simplicity to support more patients in more places. LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new
London, April 4, 2018 – LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology company, today announced it closed its acquisition of TandemLife. Previously, on Feb. 14, LivaNova announced its intent to acquire TandemLife, a privately held company focused on advanced cardiopulmonary temporary support solutions. “The acquisition of TandemLife allows us to complement
The priming tray was designed to provide hospitals with a simple, repeatable priming process that can be implemented quickly wherever cardiopulmonary support is needed. Contact us here to learn more.
We were honored to be invited to be interviewed on TechVibe Radio produced by the Pittsburgh Technology Council (PTC). The weekly show features PTC CEO Audrey Russo and Director of Visibility Jonathan Kersting talking with the pacesetters in Pittsburgh’s technology and entrepreneurial community. Our COO, Travis Deschamps, sat down with Audrey and Jonathan for a candid
Pittsburgh-based medical device company CardiacAssist Inc. has changed its name to TandemLife to better reflect its future, and it has plans to nearly double the size of the company in 18 months. Privately held CardiacAssist began life 1996 and in 2001 rolled out its first product, TandemHeart, which provides people who need it with cardiac support. But
Newly formed TandemLife will offer several innovative product lines to help medical professionals improve the quality of care for patients in need of advanced cardiac and respiratory support. PITTSBURGH, Penn., March 31, 2016 (PR Newswire) — CardiacAssist, Inc. today announced a rebranding of the privately-held company and will begin to do business as TandemLife as it rolls
TandemLung is the newest addition to an expanding portfolio of medical devices offered by the manufacturer of the world’s first percutaneous circulatory support platform. PITTSBURGH, Penn., March 15, 2016 (PR Newswire) — CardiacAssist, Inc. today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration for its new TandemLung® oxygenator, a
Texas man is the world’s first to receive the PROTEK Duo for treatment following surgery CardiacAssist, Inc. today announced that the first PROTEK Duo veno-venous extracorporeal life support (VV ECLS) kit was utilized on Wednesday, September 24th, at Memorial Hermann Hospital in Houston, Texas. According to statements from the world-renowned heart failure team led by